Inspire Pharmaceuticals, Inc. (ISPH)

Fiskhus (82.62) Submitted: 2/24/2009 11:22:53 PM : Start Price: $3.74 ISPH Score: -7.36

LMS= AA* 1%50 = AorN

cashsage (77.50) Submitted: 1/7/2009 4:18:40 PM : Start Price: $3.29 ISPH Score: -32.94

ISPH has a too high valuation compared to its sales potential. It is also loss making and does not distribute any dividend. ISPH changed rating from 3 stars to 2 stars yesterday.

manvsmonkey (77.12) Submitted: 6/20/2008 2:53:26 PM : Start Price: $4.33 ISPH Score: +33.04

ISV - don't know why that stock is dropping. Their product is solid and has potential for many permutations.

ISPH might be a better bet monetarily since they have the license to market the Azasite brand.

quoted from ISV website-

"Inspire Pharmaceuticals (NASDAQ:ISPH) has the responsibility to commercialize AzaSite in the U.S. and Canada in accordance with a completed license agreement. Ongoing activities are focused on licensing AzaSite in markets outside of the U.S. and Canada. "

HINDSMONEY (28.21) Submitted: 6/7/2008 10:53:17 PM : Start Price: $5.06 ISPH Score: +18.89

PEOPLE ARE MORE SICK

Dublin063 (91.62) Submitted: 6/6/2008 12:22:48 PM : Start Price: $5.56 ISPH Score: +10.29

A biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products in disease areas with commercial potential or unmet medical needs.

EdgarVerona (42.30) Submitted: 9/30/2007 10:28:02 PM : Start Price: $5.39 ISPH Score: +20.38

It's success will be partly due to the success of Azasite (created by its partner, ISV). I see the stock having better days soon.

SapphireSeas (80.25) Submitted: 8/12/2007 9:51:28 AM : Start Price: $5.84 ISPH Score: +9.35

Possible takeover target.

jc33sil22 (< 20) Submitted: 8/9/2007 11:39:02 AM : Start Price: $6.19 ISPH Score: -5.07

the price just hit the few month high. the resistance at this level is very high. the relative strength is deteriorating.

rfields576 (82.47) Submitted: 7/19/2007 3:05:49 AM : Start Price: $6.27 ISPH Score: +7.71

Everyone likes drugs, right?

majakblue (< 20) Submitted: 5/16/2007 9:06:54 PM : Start Price: $6.29 ISPH Score: -5.20

Big pharma wannabe. By the time it becomes profitable, the management will probably be tired of running the business and run it into the ground. At least that is the usual pattern.

0l0l (26.74) Submitted: 4/17/2007 10:46:53 PM : Start Price: $6.87 ISPH Score: -4.34

Non-sedating, highly selective antihistamine in development.